Je was op zoek naar: sulfonamides (Maltees - Engels)

sulfonamides
sulfonamides

sulfonamides (użati fil-kura ta’ infezzjonijiet)
sulfonamides (used to treat infections).

sensittività eċċessiva għal sulfonamides (ara sezzjoni 4. 4).
hypersensitivity to sulphonamides (see section 4.4).

- jekk inti allerġiku għall- mediċini li jisejħu sulfonamides.
- if you are allergic to medicines called sulphonamides.

sensittività eċċessiva għal zonisamide, għal xi sustanzi mhux attivi jew għal sulfonamides.
hypersensitivity to zonisamide, to any of the excipients or to sulphonamides.

sensittività eċċessiva magħrufa għal sulfonamides (ara wkoll sezzjoni 4.4).
known hypersensitivity to sulphonamides (see also section 4.4).

l-istess tipi ta’ reazzjonijiet avversi li huma attribwiti lil sulfonamides jistgħu jseħħu meta jintużaw topikament.
the same types of adverse reactions that are attributable to sulphonamides may occur with topical administration.

ipersensittività għas-sustanza attiva, jew għal kwalunkwe eċċipjent elenkat fit-taqsima 6.1 jew sulfonamides.
hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to sulphonamides.

grupp farmako-terapewtiku: sistema kardjovaskulari, dijuretiċi ta' limitu għoli, sulfonamides mhux kumplessi.
pharmacotherapeutic group: cardiovascular system, high-ceiling diuretics, plain sulfonamides.

għalhekk, l- istess effetti mhux mixtieqa relatati mas- sulfonamides jistgħu jidhru meta jiġu wżati b’ mod topiku.
the same types of undesirable effects that are attributable to sulphonamides may occur with topical administration.

għal-lista kompleta ta’ sustanzi jekk jogħġbok ara sezzjoni 6. jekk inti allerġiku għall-mediċini li jissejħu sulfonamides.
for a full list of ingredients please see section 6. if you are allergic to medicines called sulphonamides.

sensittività eċċessiva għas-sustanza attiva, għal kwalunkwe wieћed mill-eċċipjenti elenkati fis-sezzjoni 6.1 jew għal sulfonamides.
hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to sulfonamides.

ma’ l-għoti topika jistgħu jseħħu l-istess tipi ta’ reazzjonijiet avversi li huma attribwiti lis-sulfonamides.
the same types of adverse reactions that are attributable to sulphonamides may occur with topical administration.

nies b'sensittività eċċessiva magħrufa (allerġija) għal torasemide jew sulfonamides oħrajn għandhom jingħataw il-mediċina b'attenzjoni.
people with known hypersensitivity (allergy) to torasemide or other sulphonamides should give the medicine with caution.

coaprovel m’ għandux jintuża f’ nies li huma ipersensittivi (allerġiċi) għal irbesartan, hydrochlorothiazide, sulfonamides, jew għal xi sustanza oħra tiegħu.
coaprovel should not be used in people who may be hypersensitive (allergic) to irbesartan, hydrochlorothiazide, sulfonamides, or any of the other ingredients.

sustanzi li jistgħu jżidu l- attività biex jonqos il- livell tal- glukosju fid- demm u jżidu s- suxxettibilità għall- ipogliċemija jinkludu s- sustanzi orali anti- dijabetiċi, inibituri ta ’ l- enzima li tikkonverti angiotensin (ace), disopyramide, fibrates, fluoxetine, inibituri ta ’ monamine oxidase (maois), pentoxifylline, propoxyphene, salicylates and l- antibijotiċi sulfonamides.
substances that may enhance the blood-glucose-lowering activity and increase susceptibility to hypoglycaemia include oral antidiabetic agents, angiotensin converting enzyme (ace) inhibitors, disopyramide, fibrates, fluoxetine, monoamide oxidase inhibitors (maois), pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics.